Terje Tollali

Bodo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Initial Experience after Transition to Immune Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer Treated in a Rural Healthcare Region.

Initial Experience after Transition to Immune Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer Treated in a Rural Healthcare Region.

Journal: Cureus

Published: March 27, 2020

A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.

A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.

Journal: Cancer investigation

Published: January 11, 2018

Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain-a model-based analysis.

Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain-a model-based analysis.

Journal: ESMO open

Published: May 24, 2017

Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival?

Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival?

Journal: Journal of clinical medicine research

Published: March 10, 2017

External Validation of a Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.

External Validation of a Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.

Journal: Clinical lung cancer

Published: November 11, 2016

Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer.

Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: January 07, 2016

Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.

Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 24, 2015

Nontargeted Effect after Radiotherapy in a Patient with Non-Small Cell Lung Cancer and Bullous Pemphigoid.

Nontargeted Effect after Radiotherapy in a Patient with Non-Small Cell Lung Cancer and Bullous Pemphigoid.

Journal: Case reports in oncological medicine

Published: June 15, 2015

Active anticancer treatment during the final month of life in patients with non-small cell lung cancer.

Active anticancer treatment during the final month of life in patients with non-small cell lung cancer.

Journal: Anticancer research

Published: February 11, 2014

Oligometastatic non-small cell lung cancer: a significant entity outside of specialized cancer centers?

Oligometastatic non-small cell lung cancer: a significant entity outside of specialized cancer centers?

Journal: Medical principles and practice : international journal of the Kuwait University, Health Science Centre

Published: February 09, 2014

A population-based study of the pattern of terminal care and hospital death in patients with non-small cell lung cancer.

A population-based study of the pattern of terminal care and hospital death in patients with non-small cell lung cancer.

Journal: Anticancer research

Published: January 04, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026